Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
E

Failure to Respond to Pharmacy Recommendations for Medication Regimen Reviews

Fall River Mills, California Survey Completed on 08-07-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when pharmacy recommendations were not followed or responded to by the physician, DON, or nursing staff for three of six sampled residents over periods extending up to ten months. For one resident with dementia, chronic kidney disease, and emphysema, the physician failed to respond to the pharmacist's recommendations regarding the use of Rexulti for agitation for five months. Another resident with a history of stroke, dementia, and nerve pain had a high-risk medication combination of gabapentin and an opioid, with the pharmacist requesting a risk-benefit analysis and effectiveness documentation, but the physician did not respond for ten months. A third resident with dementia and aggressive behaviors was prescribed Zyprexa, and the pharmacist's repeated recommendations for a gradual dose reduction and improved behavior documentation went unaddressed for four consecutive months. The facility's policy required that the consultant pharmacist review medication regimens and that the physician respond to recommendations, documenting the rationale for continuing medications if indicated. However, clinical record reviews showed a lack of physician or nursing staff response to the pharmacist's recommendations in the medical records for the residents involved. The pharmacist confirmed that reminders were given to the DON and nursing staff regarding the need for specific behavior documentation and consideration of dose reductions, but these recommendations remained unaddressed.

An unhandled error has occurred. Reload 🗙